Revance Therapeutics, Inc. $2,905,210 Glaukos Corp $3,578,791 Si-Bone, Inc. $0 Revance Therapeutics, Inc. $2,905,210 Glaukos Corp $3,578,791 Si-Bone, Inc. $0